Cargando…
Resection of oesophageal and oesophagogastric junction cancer liver metastases — a summary of current evidence
PURPOSE: Metastatic oesophageal cancer is commonly considered as a palliative situation with a poor prognosis. However, there is increasing evidence that well-selected patients with a limited number of liver metastases (ECLM) may benefit from a multimodal approach including surgery. METHODS: A syste...
Autores principales: | Weiss, Andreas R. R., Donlon, Noel E., Schlitt, Hans J., Hackl, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151540/ https://www.ncbi.nlm.nih.gov/pubmed/34860291 http://dx.doi.org/10.1007/s00423-021-02387-3 |
Ejemplares similares
-
Dose-escalated neoadjuvant chemoradiotherapy for locally advanced oesophageal or oesophagogastric junctional adenocarcinoma
por: Duque-Santana, Victor, et al.
Publicado: (2022) -
Outcome of microscopically non-radical oesophagectomy for oesophageal and oesophagogastric junctional cancer: nationwide cohort study
por: Hollertz, P, et al.
Publicado: (2021) -
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium
por: Hoyo, Cathrine, et al.
Publicado: (2012) -
Opposing Immune-Metabolic Signature in Visceral Versus Subcutaneous Adipose Tissue in Patients with Adenocarcinoma of the Oesophagus and the Oesophagogastric Junction
por: Heeran, Aisling B., et al.
Publicado: (2021) -
The future of combination immunotherapy in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2023)